A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodeficiency virus-1-infected children

Donald B. Kohn, Gerhard Bauer, C. Robert Rice, J. C. Rothschild, Denise A. Carbonaro, Penelope Valdez, Qian Lin Hao, Chen Zhou, Ingrid Bahner, Karen Kearns, Kate Brody, Sarah Fox, Elizabeth Haden, Kathy Wilson, Cathy Salata, Cathy Dolan, Charles Wetter, Estuardo Aguilar-Cordova, Joseph Church

Research output: Contribution to journalArticle

181 Citations (Scopus)

Abstract

Genetic modification of hematopoietic stem cells with genes that inhibit replication of human immunodeficiency virus:1 (HIV-1) could lead to development of T lymphocytes and monocytic cells resistant to HIV-1 infection after transplantation. We performed a clinical trial to evaluate the safety and feasibility of this procedure, using bone marrow from four HIV-1-infected pediatric subjects (ages 8 to 17 years). We obtained bone marrow, isolated CD34+ cells, performed in vitro transduction with a retroviral vector carrying a rev-responsive element (RRE) decoy gene, and reinfused the cells into these subjects with no evidence of adverse effects. The levels of gene- containing leukocytes in peripheral blood samples in the I year after gene transfer/cell infusion have been extremely low. These observations support the potential of performing gene therapy for HIV-1 using hematopoietic cells, but emphasize the need for improved gene transfer techniques.

Original languageEnglish (US)
Pages (from-to)368-371
Number of pages4
JournalBlood
Volume94
Issue number1
StatePublished - Jul 1 1999
Externally publishedYes

Fingerprint

env Genes
Viruses
Bone Marrow Cells
HIV-1
Bone
Genes
Clinical Trials
Gene transfer
Gene therapy
Pediatrics
Bone Marrow
T-cells
Gene Transfer Techniques
Stem cells
Virus Diseases
Hematopoietic Stem Cells
Blood
Genetic Therapy
Leukocytes
Transplantation

ASJC Scopus subject areas

  • Hematology

Cite this

A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodeficiency virus-1-infected children. / Kohn, Donald B.; Bauer, Gerhard; Rice, C. Robert; Rothschild, J. C.; Carbonaro, Denise A.; Valdez, Penelope; Hao, Qian Lin; Zhou, Chen; Bahner, Ingrid; Kearns, Karen; Brody, Kate; Fox, Sarah; Haden, Elizabeth; Wilson, Kathy; Salata, Cathy; Dolan, Cathy; Wetter, Charles; Aguilar-Cordova, Estuardo; Church, Joseph.

In: Blood, Vol. 94, No. 1, 01.07.1999, p. 368-371.

Research output: Contribution to journalArticle

Kohn, DB, Bauer, G, Rice, CR, Rothschild, JC, Carbonaro, DA, Valdez, P, Hao, QL, Zhou, C, Bahner, I, Kearns, K, Brody, K, Fox, S, Haden, E, Wilson, K, Salata, C, Dolan, C, Wetter, C, Aguilar-Cordova, E & Church, J 1999, 'A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodeficiency virus-1-infected children', Blood, vol. 94, no. 1, pp. 368-371.
Kohn, Donald B. ; Bauer, Gerhard ; Rice, C. Robert ; Rothschild, J. C. ; Carbonaro, Denise A. ; Valdez, Penelope ; Hao, Qian Lin ; Zhou, Chen ; Bahner, Ingrid ; Kearns, Karen ; Brody, Kate ; Fox, Sarah ; Haden, Elizabeth ; Wilson, Kathy ; Salata, Cathy ; Dolan, Cathy ; Wetter, Charles ; Aguilar-Cordova, Estuardo ; Church, Joseph. / A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodeficiency virus-1-infected children. In: Blood. 1999 ; Vol. 94, No. 1. pp. 368-371.
@article{ac27e48f93bf4ff1a689f252c47ee98e,
title = "A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodeficiency virus-1-infected children",
abstract = "Genetic modification of hematopoietic stem cells with genes that inhibit replication of human immunodeficiency virus:1 (HIV-1) could lead to development of T lymphocytes and monocytic cells resistant to HIV-1 infection after transplantation. We performed a clinical trial to evaluate the safety and feasibility of this procedure, using bone marrow from four HIV-1-infected pediatric subjects (ages 8 to 17 years). We obtained bone marrow, isolated CD34+ cells, performed in vitro transduction with a retroviral vector carrying a rev-responsive element (RRE) decoy gene, and reinfused the cells into these subjects with no evidence of adverse effects. The levels of gene- containing leukocytes in peripheral blood samples in the I year after gene transfer/cell infusion have been extremely low. These observations support the potential of performing gene therapy for HIV-1 using hematopoietic cells, but emphasize the need for improved gene transfer techniques.",
author = "Kohn, {Donald B.} and Gerhard Bauer and Rice, {C. Robert} and Rothschild, {J. C.} and Carbonaro, {Denise A.} and Penelope Valdez and Hao, {Qian Lin} and Chen Zhou and Ingrid Bahner and Karen Kearns and Kate Brody and Sarah Fox and Elizabeth Haden and Kathy Wilson and Cathy Salata and Cathy Dolan and Charles Wetter and Estuardo Aguilar-Cordova and Joseph Church",
year = "1999",
month = "7",
day = "1",
language = "English (US)",
volume = "94",
pages = "368--371",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodeficiency virus-1-infected children

AU - Kohn, Donald B.

AU - Bauer, Gerhard

AU - Rice, C. Robert

AU - Rothschild, J. C.

AU - Carbonaro, Denise A.

AU - Valdez, Penelope

AU - Hao, Qian Lin

AU - Zhou, Chen

AU - Bahner, Ingrid

AU - Kearns, Karen

AU - Brody, Kate

AU - Fox, Sarah

AU - Haden, Elizabeth

AU - Wilson, Kathy

AU - Salata, Cathy

AU - Dolan, Cathy

AU - Wetter, Charles

AU - Aguilar-Cordova, Estuardo

AU - Church, Joseph

PY - 1999/7/1

Y1 - 1999/7/1

N2 - Genetic modification of hematopoietic stem cells with genes that inhibit replication of human immunodeficiency virus:1 (HIV-1) could lead to development of T lymphocytes and monocytic cells resistant to HIV-1 infection after transplantation. We performed a clinical trial to evaluate the safety and feasibility of this procedure, using bone marrow from four HIV-1-infected pediatric subjects (ages 8 to 17 years). We obtained bone marrow, isolated CD34+ cells, performed in vitro transduction with a retroviral vector carrying a rev-responsive element (RRE) decoy gene, and reinfused the cells into these subjects with no evidence of adverse effects. The levels of gene- containing leukocytes in peripheral blood samples in the I year after gene transfer/cell infusion have been extremely low. These observations support the potential of performing gene therapy for HIV-1 using hematopoietic cells, but emphasize the need for improved gene transfer techniques.

AB - Genetic modification of hematopoietic stem cells with genes that inhibit replication of human immunodeficiency virus:1 (HIV-1) could lead to development of T lymphocytes and monocytic cells resistant to HIV-1 infection after transplantation. We performed a clinical trial to evaluate the safety and feasibility of this procedure, using bone marrow from four HIV-1-infected pediatric subjects (ages 8 to 17 years). We obtained bone marrow, isolated CD34+ cells, performed in vitro transduction with a retroviral vector carrying a rev-responsive element (RRE) decoy gene, and reinfused the cells into these subjects with no evidence of adverse effects. The levels of gene- containing leukocytes in peripheral blood samples in the I year after gene transfer/cell infusion have been extremely low. These observations support the potential of performing gene therapy for HIV-1 using hematopoietic cells, but emphasize the need for improved gene transfer techniques.

UR - http://www.scopus.com/inward/record.url?scp=0033168686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033168686&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 368

EP - 371

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -